Research demonstrates combined Bpc-157 and Tb-500 use produces approximately 30 percent faster healing versus either peptide used individually, with enhanced fibroblast activity and immune cell migration
Only HSA & FSA is accepted
Human data lacking To date, most (if not all) data is preclinical (rodents, cell culture)
An intradermal skin test should be performed if there is a hypersensitivity risk
Back to Journals Drug Design, Development and Therapy Volume 18 Therapeutic Potential of Natural Resources Against Endometriosis: Current Advances and Future Perspectives Authors Gu X, Zhou H, Miao M, Hu D, Wang X, Zhou J, Teichmann AT, Yang Y, Wang C Received 20 February 2024 Accepted for publication 9 July 2024 Published 21 August 2024 Volume 2024:18 Pages 36673696 DOI Checked for plagiarism Yes Review by Single anonymous peer review Peer reviewer comments 2 Editor who approved publication: Professor Anastasios Lymperopoulos Xia Gu, 1, 2, * Hui Zhou, 1, * Mengyue Miao, 1 Daifeng Hu, 1 Xinyue Wang, 3 Jing Zhou, 4 Alexander Tobias Teichmann, 1 Youzhe Yang, 1, 5 Chunyan Wang 1 1 Sichuan Provincial Center for Gynaecology and Breast Diseases, The Affiliated Hospital of Southwest Medical University, Luzhou, 646000, Peoples Republic of China
The results are presented as the mean SEM
